As companies shift to cloud-based systems, they're increasingly turning to these firms for secure, reliable versions of open-source tools. This ongoing transition is fueling significant growth opportunities.
These companies enjoy a unique advantage - their core products are developed by global communities for free, allowing them to focus on monetization rather than building from scratch.
From databases to DevOps tools, these companies power critical infrastructure for major corporations worldwide. Their technologies have become essential building blocks for modern business.
These companies have mastered the art of monetizing free software by providing crucial enterprise services. They leverage established user communities to create profitable businesses around technologies that were built collaboratively. This unique position gives them lower customer acquisition costs and strong technical advantages.
These stocks offer exposure to the high-growth enterprise software sector. Their business model involves selling premium features, support, and managed cloud services for widely-used open-source tools. They're particularly well-positioned as companies increasingly rely on cloud infrastructure and developer tools.
We've selected industry leaders who've built their core commercial offerings directly on specific open-source projects. These companies focus on critical areas like data infrastructure, DevOps, and cloud computing. They benefit from the ongoing shift to cloud-native systems that drives demand for their solutions.
These innovative companies turn free open-source software into thriving businesses. Carefully selected by our analysts, these stocks represent firms that have built powerful commercial models around community-developed technologies while serving as gateways to global innovation.
Summary and investor takeaways for the Open-Source Champions basket based on provided market capitalisation data.
MDB: $26.50B
ESTC: $9.21B
GTLB: $8.25B
Erfahren Sie alles über diesen Aktienkorb. Lesen Sie unseren ausführlichen Artikel zu seinen Risiken und seinem Potenzial.
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Part of Exinity Group 2015, serving over a million customers globally.
Earn 6% AER on uninvested cash with daily interest payments.
+3
Gilead Sciences has secured FDA approval for a new once-daily HIV combination pill, streamlining therapy for millions of suppressed patients. This regulatory milestone spotlights investment opportunities in pioneering biopharmaceutical companies and drug delivery developers focused on advanced antiviral treatments.
Disney is suing the FCC to block an early license review of its ABC stations, arguing the move is politically motivated retaliation against its news coverage. This unprecedented legal battle highlights the growing regulatory risks for traditional broadcasters and underscores the structural advantages of unregulated digital streaming platforms.
SK Hynix has unveiled a record-breaking 40 trillion won share buyback fueled by soaring demand for its AI memory chips. This historic capital return creates a compelling investment theme centered on high-bandwidth memory producers and the specialized equipment manufacturers that enable their advanced production.
Here are a few of the assets in this group. Create an account to unlock the full list.
Use the growth calculator to see how much investing in these assets could return over one year, based on aggregated analyst sentiment provided by Refinitive Ltd.
Wenn Sie in diese Werte investieren:
In 12 Monaten könnte der Wert betragen:
+14.90%
Analysten erwarten im Durchschnitt, dass die Werte dieser Gruppe im nächsten Jahr um 14.9 % zulegen.
10 von 12 Werten dieser Gruppe werden von professionellen Analysten mit „Kaufen“ bewertet.
